nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00774	0.00813	CbGpPWpGaD
Ticagrelor—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.00772	0.00811	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00768	0.00807	CbGpPWpGaD
Ticagrelor—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00746	0.00784	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00745	0.00782	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00736	0.00773	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00719	0.00756	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00658	0.00691	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00644	0.00677	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PDE3B—polycystic ovary syndrome	0.00632	0.00665	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00596	0.00626	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00589	0.00619	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00567	0.00596	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.00566	0.00595	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—LHB—polycystic ovary syndrome	0.0056	0.00589	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00548	0.00575	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—RACGAP1—polycystic ovary syndrome	0.00542	0.00569	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00541	0.00569	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00539	0.00566	CbGpPWpGaD
Ticagrelor—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00533	0.00559	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00528	0.00554	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00528	0.00554	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00525	0.00552	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00501	0.00526	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00497	0.00523	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00497	0.00523	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.00497	0.00522	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00489	0.00514	CbGpPWpGaD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00487	0.00512	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00486	0.0051	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00469	0.00493	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00469	0.00493	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00465	0.00489	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00452	0.00475	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00452	0.00475	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00452	0.00475	CbGpPWpGaD
Ticagrelor—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00443	0.00466	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00439	0.00462	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.00434	0.00456	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00422	0.00444	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.0041	0.00431	CbGpPWpGaD
Ticagrelor—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00407	0.00428	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00402	0.00423	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.004	0.0042	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00399	0.00419	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.00395	0.00415	CbGpPWpGaD
Ticagrelor—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00392	0.00412	CbGpPWpGaD
Ticagrelor—Contusion—Metformin—polycystic ovary syndrome	0.00391	0.081	CcSEcCtD
Ticagrelor—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00376	0.00396	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.0037	0.00389	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00366	0.00384	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00364	0.00382	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00363	0.00381	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00333	0.0035	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PLAT—polycystic ovary syndrome	0.00331	0.00348	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00331	0.00347	CbGpPWpGaD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00327	0.00344	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.0032	0.00337	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NPB—polycystic ovary syndrome	0.0032	0.00336	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.00319	0.00335	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.00319	0.00335	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00317	0.00333	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00316	0.00332	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.0031	0.00325	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00306	0.00322	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.00303	0.00318	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00302	0.00318	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00297	0.00312	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00291	0.00306	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00289	0.00304	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00288	0.00302	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00285	0.003	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00284	0.00298	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00283	0.00297	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00282	0.00296	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00281	0.00295	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00269	0.00283	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00267	0.00281	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00267	0.0028	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00267	0.0028	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00265	0.00279	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00262	0.00275	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.0026	0.00273	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00257	0.0027	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—GNAS—polycystic ovary syndrome	0.00254	0.00267	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00251	0.00264	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.0025	0.00262	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00249	0.00262	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00243	0.00256	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00242	0.00255	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00236	0.00248	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00231	0.00243	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—INHBB—polycystic ovary syndrome	0.0023	0.00241	CbGpPWpGaD
Ticagrelor—Breast disorder—Metformin—polycystic ovary syndrome	0.00224	0.0463	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.00221	0.00232	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00215	0.00226	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00214	0.00225	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.0021	0.00221	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00209	0.0022	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00209	0.0022	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.00208	0.00219	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00207	0.00218	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00201	0.00212	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00195	0.00205	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00191	0.00201	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.0019	0.00199	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00184	0.00193	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00179	0.00188	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00178	0.00187	CbGpPWpGaD
Ticagrelor—Bradycardia—Metformin—polycystic ovary syndrome	0.00174	0.0361	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—FST—polycystic ovary syndrome	0.00174	0.00183	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.00173	0.00182	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00173	0.00182	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00172	0.00181	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.0017	0.00179	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LHB—polycystic ovary syndrome	0.0017	0.00178	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00169	0.00178	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00169	0.00177	CbGpPWpGaD
Ticagrelor—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00169	0.035	CcSEcCtD
Ticagrelor—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00168	0.0349	CcSEcCtD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00167	0.00175	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00166	0.00174	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IGF1—polycystic ovary syndrome	0.00164	0.00173	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT2—polycystic ovary syndrome	0.00164	0.00173	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00161	0.00169	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00161	0.00169	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.0016	0.00169	CbGpPWpGaD
Ticagrelor—Eye disorder—Metformin—polycystic ovary syndrome	0.0016	0.0332	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—SCT—polycystic ovary syndrome	0.00159	0.00167	CbGpPWpGaD
Ticagrelor—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00159	0.0329	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00157	0.00165	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00156	0.00164	CbGpPWpGaD
Ticagrelor—Angiopathy—Metformin—polycystic ovary syndrome	0.00155	0.0322	CcSEcCtD
Ticagrelor—Immune system disorder—Metformin—polycystic ovary syndrome	0.00155	0.032	CcSEcCtD
Ticagrelor—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00154	0.032	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00152	0.0016	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00149	0.00157	CbGpPWpGaD
Ticagrelor—Malnutrition—Metformin—polycystic ovary syndrome	0.00149	0.0309	CcSEcCtD
Ticagrelor—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00149	0.00156	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00148	0.00156	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00146	0.00153	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00139	0.00146	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00138	0.00145	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00137	0.00144	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00137	0.00144	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00136	0.00143	CbGpPWpGaD
Ticagrelor—Syncope—Metformin—polycystic ovary syndrome	0.00134	0.0277	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00131	0.00138	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00131	0.0271	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—INSR—polycystic ovary syndrome	0.0013	0.00137	CbGpPWpGaD
Ticagrelor—Hypertension—Metformin—polycystic ovary syndrome	0.00129	0.0267	CcSEcCtD
Ticagrelor—Chest pain—Metformin—polycystic ovary syndrome	0.00127	0.0263	CcSEcCtD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00126	0.00133	CbGpPWpGaD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00126	0.0261	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00124	0.0013	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00123	0.00129	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00122	0.00128	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00121	0.00127	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PGR—polycystic ovary syndrome	0.00121	0.00127	CbGpPWpGaD
Ticagrelor—Shock—Metformin—polycystic ovary syndrome	0.0012	0.0248	CcSEcCtD
Ticagrelor—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00119	0.0247	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.00119	0.00125	CbGpPWpGaD
Ticagrelor—Skin disorder—Metformin—polycystic ovary syndrome	0.00118	0.0245	CcSEcCtD
Ticagrelor—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00114	0.0012	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00114	0.0012	CbGpPWpGaD
Ticagrelor—Hypotension—Metformin—polycystic ovary syndrome	0.00114	0.0236	CcSEcCtD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00113	0.00118	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00112	0.00118	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00112	0.00118	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00112	0.00117	CbGpPWpGaD
Ticagrelor—Paraesthesia—Metformin—polycystic ovary syndrome	0.00109	0.0226	CcSEcCtD
Ticagrelor—Dyspnoea—Metformin—polycystic ovary syndrome	0.00108	0.0225	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00108	0.00114	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—polycystic ovary syndrome	0.00107	0.00113	CbGpPWpGaD
Ticagrelor—Dyspepsia—Metformin—polycystic ovary syndrome	0.00107	0.0222	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00107	0.00112	CbGpPWpGaD
Ticagrelor—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00105	0.0218	CcSEcCtD
Ticagrelor—Fatigue—Metformin—polycystic ovary syndrome	0.00105	0.0217	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00104	0.0011	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00104	0.00109	CbGpPWpGaD
Ticagrelor—Constipation—Metformin—polycystic ovary syndrome	0.00104	0.0216	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00104	0.00109	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.00103	0.00108	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00102	0.00107	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Metformin—polycystic ovary syndrome	0.001	0.0208	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000994	0.0206	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000987	0.00104	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000981	0.00103	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRL—polycystic ovary syndrome	0.000979	0.00103	CbGpPWpGaD
Ticagrelor—Abdominal pain—Metformin—polycystic ovary syndrome	0.000961	0.0199	CcSEcCtD
Ticagrelor—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000951	0.000999	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000951	0.000999	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000943	0.000991	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000928	0.000975	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000904	0.00095	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000891	0.000937	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000884	0.000929	CbGpPWpGaD
Ticagrelor—Asthenia—Metformin—polycystic ovary syndrome	0.000872	0.0181	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000861	0.000905	CbGpPWpGaD
Ticagrelor—Pruritus—Metformin—polycystic ovary syndrome	0.00086	0.0178	CcSEcCtD
Ticagrelor—Diarrhoea—Metformin—polycystic ovary syndrome	0.000832	0.0172	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00082	0.000862	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000805	0.000846	CbGpPWpGaD
Ticagrelor—Dizziness—Metformin—polycystic ovary syndrome	0.000804	0.0167	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00078	0.000819	CbGpPWpGaD
Ticagrelor—Vomiting—Metformin—polycystic ovary syndrome	0.000773	0.016	CcSEcCtD
Ticagrelor—Rash—Metformin—polycystic ovary syndrome	0.000767	0.0159	CcSEcCtD
Ticagrelor—Dermatitis—Metformin—polycystic ovary syndrome	0.000766	0.0159	CcSEcCtD
Ticagrelor—Headache—Metformin—polycystic ovary syndrome	0.000762	0.0158	CcSEcCtD
Ticagrelor—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000752	0.00079	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000752	0.00079	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000729	0.000765	CbGpPWpGaD
Ticagrelor—Nausea—Metformin—polycystic ovary syndrome	0.000722	0.015	CcSEcCtD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000718	0.000755	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00069	0.000724	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000681	0.000715	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LEP—polycystic ovary syndrome	0.000675	0.000709	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00067	0.000704	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000641	0.000673	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00063	0.000662	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000623	0.000654	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000602	0.000632	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000597	0.000628	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000586	0.000616	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000586	0.000616	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—POMC—polycystic ovary syndrome	0.00058	0.000609	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—INS—polycystic ovary syndrome	0.000576	0.000606	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.00057	0.000599	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00057	0.000599	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000558	0.000586	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000557	0.000585	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000545	0.000572	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000543	0.000571	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000529	0.000556	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000509	0.000535	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000508	0.000534	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000485	0.000509	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000478	0.000502	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000463	0.000487	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000463	0.000487	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000442	0.000464	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000432	0.000454	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000426	0.000448	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000418	0.000439	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000388	0.000408	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000385	0.000404	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000373	0.000392	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000368	0.000387	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000364	0.000383	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000359	0.000378	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000351	0.000369	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000345	0.000363	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000341	0.000358	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000322	0.000338	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000317	0.000333	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000313	0.000329	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000299	0.000314	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TH—polycystic ovary syndrome	0.000274	0.000288	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000272	0.000286	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000267	0.00028	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000266	0.00028	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000258	0.000271	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—polycystic ovary syndrome	0.000252	0.000265	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000251	0.000264	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000237	0.000249	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.00023	0.000241	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	0.000224	0.000235	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000221	0.000233	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	0.000213	0.000224	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000213	0.000224	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.00021	0.000221	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000202	0.000212	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000198	0.000208	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000195	0.000205	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	0.000189	0.000198	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TH—polycystic ovary syndrome	0.000169	0.000178	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000164	0.000173	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000155	0.000162	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	0.000153	0.000161	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—POMC—polycystic ovary syndrome	0.000151	0.000158	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—INS—polycystic ovary syndrome	0.00015	0.000158	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	0.000138	0.000145	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	0.000131	0.000138	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000125	0.000131	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	0.000116	0.000122	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	9.42e-05	9.9e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	9.29e-05	9.76e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—INS—polycystic ovary syndrome	9.24e-05	9.71e-05	CbGpPWpGaD
